26 April 2019 Vol 364, Issue 6438
Dengue researcher faces charges in vaccine fiasco
By Fatima Arkin
Science26 Apr 2019 : 320 Restricted Access
Rose Capeding could face years in prison for role in tests.
Rose Capeding, former head of the dengue department of the Research Institute for Tropical Medicine in Manila, has been indicted in a series of criminal cases over the failed introduction in the Philippines of Dengvaxia, a vaccine against dengue that was yanked from the market in 2017 because of safety issues. In February, a panel of prosecutors concluded that there is probable cause to indict Capeding and 19 others for “reckless imprudence resulting [in] homicide,” because of their role in the vaccine’s approval and rollout. If convicted of accusations leveled at her by the national Department of Justice, Capeding could face up to 48 years in prison. Many scientists have come to her defense.